A Clinical Study Comparing the Effectiveness of Amruthadi Kashaya and Haridrakhanda in Treating Sheetapitta ( urticaria)

A RANDOMIZED OPEN-LABEL CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF AMRUTHADI KASHAYA IN THE MANAGEMENT OF SHEETAPITTA WITH SPECIAL REFERENCE TO URTICARIA AND COMPARE WITH THE EFFICACY OF HARIDRAKHANDA - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105855

Enrollment

Registered

2026-03-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients presenting with classical signs and symptoms of sheetapitta such as varatee dashta samsthana shotha,kandu and toda 2 Patients exhibits symptoms falling within mild to moderate range on the UAS urticaria scale. 3 Subjects willing to participate with written informed consent, which is conveyed in the language, which the subject can understand.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women. 2. Presence of uncontrolled systemic disorders such as diabetic mellitus, hypertention, IHD that may interfere course of disease or treatment response. 3. Known hypersensitivity or allergy to ingredients of the intervention drug or formulation 4. Use of systemic antihistamines, corticosteroids, immunomodulators.

Design outcomes

Primary

Measure	Time frame
To clinically evaluate the efficacy of Amruthadi kashaya in the management of Sheetapitta with special reference to Urticaria based on subjective and objective parameters in the Institutional clinical setupTimepoint: 0th day -pre-test assessment with subjective and UAS scale 31st day post-test assessment with subjective and UAS scale 46th day as drug free follow-up assessment with subjective and UAS scale	—

Measure

Time frame

To clinically evaluate the efficacy of Amruthadi kashaya in the management of Sheetapitta with special reference to Urticaria based on subjective and objective parameters in the Institutional clinical setupTimepoint: 0th day -pre-test assessment with subjective and UAS scale 31st day post-test assessment with subjective and UAS scale 46th day as drug free follow-up assessment with subjective and UAS scale

—

Secondary

Measure	Time frame
1. To assess the quality of life of patients through General Health Questionnaire Scale. 2.To undertake the detailed literary review of Sheetapitta ,Amruthadi Kashaya ,Haridrakhanda for study of sheetapitta with special reference to Urticaria 3.To record and report adverse effect (if any ) during the study periodTimepoint: 0th day -pre-test assessment with subjective and UAS scale 31st day post-test assessment with subjective and UAS scale 46th day as drug free follow-up assessment with subjective and UAS scale	—

Measure

Time frame

1. To assess the quality of life of patients through General Health Questionnaire Scale. 2.To undertake the detailed literary review of Sheetapitta ,Amruthadi Kashaya ,Haridrakhanda for study of sheetapitta with special reference to Urticaria 3.To record and report adverse effect (if any ) during the study periodTimepoint: 0th day -pre-test assessment with subjective and UAS scale 31st day post-test assessment with subjective and UAS scale 46th day as drug free follow-up assessment with subjective and UAS scale

—

Countries

India

Contacts

Public ContactDR GOPALAKRISHNA G

SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH HOSPITAL

lakshmimp1981@gmail.com9448173128

Outcome results